Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan Choi

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
Antimicrobial Agents and Chemotherapy|April 18, 2018
Therapeutic Efficacy of Bumped Kinase Inhibitor 1369 in a Pig Model of Acute Diarrhea Caused by Cryptosporidium hominisSangun Lee, Melanie Ginese, Gillian Beamer, et al.
The Journal of Infectious Diseases|May 4, 2026
Structure-guided design of calcium-dependent protein kinase 1 (CDPK1) inhibitors for cryptosporidiosisWissarut Wijitrmektong, Ryan Choi, Matthew A Hulverson, et al.
Acta Crystallographica. Section F, Structural Biology Communications|November 11, 2025
Crystal structure of a short-chain dehydrogenase from Brucella ovis with apo and coenzyme NAD<sup>+</sup>-bound protomer chainsSean P Zupko, Amelia T Konstanty, Steve J Mayclin, et al.
ACS Infectious Diseases|March 10, 2018
7 H-Pyrrolo[2,3- d]pyrimidin-4-amine-Based Inhibitors of Calcium-Dependent Protein Kinase 1 Have Distinct Inhibitory and Oral Pharmacokinetic Characteristics Compared with 1 H-Pyrazolo[3,4- d]pyrimidin-4-amine-Based InhibitorsRama S R Vidadala, Martin Golkowski, Matthew A Hulverson, et al.
International Journal for Parasitology. Drugs and Drug Resistance|September 5, 2021
Endochin-like quinolones (ELQs) and bumped kinase inhibitors (BKIs): Synergistic and additive effects of combined treatments against Neospora caninum infection in vitro and in vivoNicoleta Anghel, Dennis Imhof, Pablo Winzer, et al.
Gut|November 19, 2017
Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre studyChang-Ho Ryan Choi, Ibrahim Al Bakir, Nik-Sheng John Ding, et al.
Antimicrobial Agents and Chemotherapy|May 24, 2017
5-Aminopyrazole-4-Carboxamide-Based Compounds Prevent the Growth of Cryptosporidium parvumWenlin Huang, Ryan Choi, Matthew A Hulverson, et al.
International Journal for Parasitology. Drugs and Drug Resistance|May 24, 2021
In vitro activity, safety and in vivo efficacy of the novel bumped kinase inhibitor BKI-1748 in non-pregnant and pregnant mice experimentally infected with Neospora caninum tachyzoites and Toxoplasma gondii oocystsDennis Imhof, Nicoleta Anghel, Pablo Winzer, et al.
Plos One|August 9, 2016
Brucella melitensis Methionyl-tRNA-Synthetase (MetRS), a Potential Drug Target for BrucellosisKayode K Ojo, Ranae M Ranade, Zhongsheng Zhang, et al.
Antimicrobial Agents and Chemotherapy|January 2, 2025
Treatment with BKI-1748 after <i>Toxoplasma gondii</i> systemic dissemination in experimentally infected pregnant sheep improves fetal and lamb mortality and morbidity and prevents congenital infectionRoberto Sánchez-Sánchez, Ana Huertas-López, Andrea Largo-de la Torre, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
Antimicrobial Agents and Chemotherapy|April 18, 2018
Therapeutic Efficacy of Bumped Kinase Inhibitor 1369 in a Pig Model of Acute Diarrhea Caused by Cryptosporidium hominisSangun Lee, Melanie Ginese, Gillian Beamer, et al.
The Journal of Infectious Diseases|May 4, 2026
Structure-guided design of calcium-dependent protein kinase 1 (CDPK1) inhibitors for cryptosporidiosisWissarut Wijitrmektong, Ryan Choi, Matthew A Hulverson, et al.
Acta Crystallographica. Section F, Structural Biology Communications|November 11, 2025
Crystal structure of a short-chain dehydrogenase from Brucella ovis with apo and coenzyme NAD<sup>+</sup>-bound protomer chainsSean P Zupko, Amelia T Konstanty, Steve J Mayclin, et al.
ACS Infectious Diseases|March 10, 2018
7 H-Pyrrolo[2,3- d]pyrimidin-4-amine-Based Inhibitors of Calcium-Dependent Protein Kinase 1 Have Distinct Inhibitory and Oral Pharmacokinetic Characteristics Compared with 1 H-Pyrazolo[3,4- d]pyrimidin-4-amine-Based InhibitorsRama S R Vidadala, Martin Golkowski, Matthew A Hulverson, et al.
International Journal for Parasitology. Drugs and Drug Resistance|September 5, 2021
Endochin-like quinolones (ELQs) and bumped kinase inhibitors (BKIs): Synergistic and additive effects of combined treatments against Neospora caninum infection in vitro and in vivoNicoleta Anghel, Dennis Imhof, Pablo Winzer, et al.
Gut|November 19, 2017
Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre studyChang-Ho Ryan Choi, Ibrahim Al Bakir, Nik-Sheng John Ding, et al.
Antimicrobial Agents and Chemotherapy|May 24, 2017
5-Aminopyrazole-4-Carboxamide-Based Compounds Prevent the Growth of Cryptosporidium parvumWenlin Huang, Ryan Choi, Matthew A Hulverson, et al.
International Journal for Parasitology. Drugs and Drug Resistance|May 24, 2021
In vitro activity, safety and in vivo efficacy of the novel bumped kinase inhibitor BKI-1748 in non-pregnant and pregnant mice experimentally infected with Neospora caninum tachyzoites and Toxoplasma gondii oocystsDennis Imhof, Nicoleta Anghel, Pablo Winzer, et al.
Plos One|August 9, 2016
Brucella melitensis Methionyl-tRNA-Synthetase (MetRS), a Potential Drug Target for BrucellosisKayode K Ojo, Ranae M Ranade, Zhongsheng Zhang, et al.
Antimicrobial Agents and Chemotherapy|January 2, 2025
Treatment with BKI-1748 after <i>Toxoplasma gondii</i> systemic dissemination in experimentally infected pregnant sheep improves fetal and lamb mortality and morbidity and prevents congenital infectionRoberto Sánchez-Sánchez, Ana Huertas-López, Andrea Largo-de la Torre, et al.
Pageof 10